38 percent of U.S. adults have tried cannabis. The average consumer age now stands at 37. Figures on market growth, medical applications, and regulatory changes map the current scale of the industry.
Key Takeaways
- 38% of U.S. adults have tried cannabis at least once, per 2023 Gallup poll
- Medical cannabis reduces opioid prescriptions by 25% in U.S. states with programs
- The global legal cannabis market was valued at $33.6 billion in 2023 and is projected to reach $444 billion by 2030, growing at a CAGR of 44.1%
- Over 500 million cannabis plants cultivated annually in Canada for legal market 2023
- 24 U.S. states have adult-use cannabis legal as of 2024, up from 0 in 2012
Cannabis industry data shows steady growth and rising demand, signaling expanding opportunities for cannabinoid businesses.
Related reading
01 · Category
Consumer Trends and Demographics30 stats
01
38% of U.S. adults have tried cannabis at least once, per 2023 Gallup poll
02
18% of U.S. adults reported current cannabis use in 2022 NSDUH survey
03
Millennials (ages 28-43) represent 42% of U.S. cannabis consumers in 2023
04
Women make up 47% of medical cannabis patients in the U.S. as of 2023
05
52% of U.S. Gen Z (18-27) have used cannabis in past year per 2023 survey
06
Black Americans comprise 18% of U.S. cannabis consumers despite 13% population share in 2023
07
65% of U.S. cannabis users prefer edibles or beverages for discreet consumption, 2023 data
08
Average U.S. cannabis consumer age is 37 in 2023, down from 40 in 2019
09
28% of U.S. parents report using cannabis since legalization in their state, 2023 survey
10
Hispanic Americans represent 22% of cannabis buyers in 2023 U.S. market data
11
71% of U.S. cannabis consumers cite relaxation/stress relief as primary reason, 2023 poll
12
Daily cannabis use among U.S. adults doubled from 4.1% in 2016 to 8.5% in 2023
13
55% of female U.S. cannabis users consume for sleep aid, vs 42% of males, 2023 data
14
Urban U.S. residents are 2.5x more likely to use cannabis than rural, 2023 stats
15
62% of U.S. seniors (65+) open to trying cannabis for pain, 2023 AARP survey
16
LGBTQ+ individuals 3x more likely to use cannabis than straight peers, 34% vs 11%, 2023
17
Average annual spend per U.S. cannabis consumer is $650in 2023
18
49% of U.S. college students used cannabis in past year, 2023 Monitoring the Future
19
Veterans represent 10% of medical cannabis patients in U.S., 2023 VA data
20
76% of U.S. cannabis tourists visit Colorado annually, 1.5 million visitors, 2023
21
Baby Boomers (58+) now 22% of U.S. market buyers, up from 15% in 2020
22
41% of U.S. consumers prefer indica strains for nighttime use, 2023 preferences
23
Online cannabis sales channel grew 35% YoY to 25% market share in 2023
24
33% of U.S. adults perceive cannabis as safer than alcohol, 2023 Gallup
25
Athletes comprise 15% of wellness cannabis users, citing recovery benefits, 2023
26
27% increase in female first-time buyers in U.S. 2023
27
East Coast U.S. consumers favor higher THC products, avg 25% vs 20% West, 2023
28
68% of Canadian cannabis users are under 45, 2023 StatCan
29
Global CBD consumer base exceeds 100 million, 40% female skew, 2023 est.
30
U.S. states with legal rec use see 15% higher prevalence among 18-25 yr olds
Interpretation
Consumer Trends and Demographics Interpretation
While the average age of the American cannabis consumer has officially dropped to a youthful 37, the market now spans from stress-relieving Millennials and sleep-seeking women to open-minded seniors and discreet-edible fans, revealing a mainstream, multifaceted industry where nearly two in five adults have at least tried it, but where legalization's uneven landscape still creates stark demographic and geographic divides.
02 · Category
Health, Medical, and Research27 stats
01
Medical cannabis reduces opioid prescriptions by 25% in U.S. states with programs
02
92% of medical cannabis users report pain relief in 2023 U.S. studies
03
CBD effective for 70% epilepsy patients in FDA-approved Epidiolex trials
04
Cannabis use disorder prevalence 9% among daily users, NIDA 2023 data
05
THC:CBD 1:1 ratios reduce chemotherapy nausea 80% better than THC alone
06
48% reduction in PTSD symptoms with medical cannabis, 2023 meta-analysis
07
U.S. veterans: 70% PTSD improvement with cannabis, per 2023 survey
08
Cannabinoids lower intraocular pressure 25% for glaucoma patients
09
60% of Crohn's disease patients achieve remission with CBD oil, 2023 trial
10
Adolescent cannabis use linked to 8 IQ point drop long-term, Dunedin study update 2023
11
Medical cannabis cuts opioid overdose deaths 35% in U.S. states, 2023 JAMA
12
82% anxiety reduction in first month of CBD use, 2023 clinical trial
13
Delta-8 THC hospitalizations up 82% 2021-2023, CDC data
14
Cannabinoids neuroprotective in Parkinson's, 40% tremor reduction
15
50,000+ U.S. clinical trials registered involving cannabinoids since 2015
16
Sleep quality improves 67% with indica strains, per 2023 user data
17
THC impairs driving 4x more than alcohol at 5ng/ml blood limit, NHTSA 2023
18
CBD reduces seizure frequency 40% in Dravet syndrome, long-term study
19
Chronic pain patients: 64% discontinue opioids after 8 months cannabis
20
Vaping cannabis causes 20% more lung irritation than smoking, 2023 study
21
Endocannabinoid system regulates 85% human immune responses, 2023 review
22
Autism symptoms improve 30% with CBD in children, Israeli trial 2023
23
High potency cannabis (>10% THC) psychosis risk 5x higher, Lancet 2023
24
Arthritis pain relief 77% with topical cannabinoids, RCT 2023
25
Pregnancy cannabis use: 2.5x preterm birth risk, CDC 2023
26
75% migraine reduction frequency with cannabis, neurology journal 2023
27
Sativex (nabiximols) approved in 30 countries for MS spasticity 2023
Interpretation
Health, Medical, and Research Interpretation
The cannabinoid industry presents a paradox of undeniable therapeutic promise shadowed by serious risks, as it offers everything from a potential weapon against the opioid crisis and profound relief for chronic conditions to the sobering realities of adolescent harm, addiction, and unregulated market dangers.
03 · Category
Market Size and Growth30 stats
01
The global legal cannabis market was valued at $33.6 billion in 2023 and is projected to reach $444 billion by 2030, growing at a CAGR of 44.1%
02
U.S. cannabis industry sales reached $29.35 billion in 2023, marking a 12% year-over-year increase
03
The CBD market size was estimated at $8.46 billion in 2023 and expected to grow at a CAGR of 15.8% from 2024 to 2030
04
North American cannabis beverage market generated $2.4 billion in sales in 2023, up 28% from 2022
05
Global hemp-derived CBD market projected to hit $22 billion by 2025, driven by wellness trends
06
U.S. recreational cannabis sales hit $24.3 billion in 2023 across 24 states
07
European cannabis market valued at €4.7 billion in 2023, with Germany leading at €1.5 billion
08
Canadian legal cannabis sales reached CAD 5.1 billion in 2023, a 25% increase YoY
09
U.S. medical cannabis market size was $14.5 billion in 2023, projected to $45.2 billion by 2030 at CAGR 17.5%
10
Global cannabinoid pharmaceuticals market expected to grow from $5.2 billion in 2023 to $12.8 billion by 2030, CAGR 13.7%
11
Illinois adult-use cannabis sales surpassed $1.6 billion in 2023
12
California cannabis market generated $5.3 billion in 2023 despite oversupply challenges
13
Global cannabis edibles market valued at $11.2 billion in 2023, CAGR 28.4% to 2030
14
U.S. hemp CBD sales estimated at $4.9 billion in 2022, declining to $3.8 billion in 2023 due to regulations
15
Michigan cannabis sales hit $3.1 billion in 2023, up 51% YoY
16
Global cannabis topicals market size reached $6.1 billion in 2023, projected CAGR 22.1%
17
New York adult-use sales exceeded $500 million in first year post-legalization in 2023
18
Australian medical cannabis market valued at AUD 200 million in 2023, CAGR 25% forecast
19
U.S. vape market in cannabis hit $2.8 billion in 2023
20
Latin America cannabis market projected from $1.2 billion in 2023 to $8.9 billion by 2030, CAGR 33.2%
21
Colorado cannabis sales totaled $2.2 billion in 2023
22
Global cannabis concentrates market size was $12.5 billion in 2023, CAGR 24.8% to 2030
23
Ohio medical cannabis sales reached $450 million in 2023
24
Israel cannabis exports hit $100 million in 2023
25
U.S. total cannabis sales forecast to reach $44 billion by 2025
26
Florida medical cannabis sales exceeded $2 billion in 2023
27
Global cannabis market CAGR projected at 25.2% from 2024-2032
28
Nevada cannabis sales hit $1.6 billion in FY2023
29
U.K. medical cannabis market reached £239 million in 2023
30
Washington state cannabis sales totaled $1.3 billion in 2023
Interpretation
Market Size and Growth Interpretation
While these figures reveal a market so explosively green it makes Wall Street look beige, remember this vertiginous growth is less about getting high and more about the serious global recalibration of wellness, medicine, and a once-demonized agricultural commodity finally cashing its long-overdue check.
More related reading
04 · Category
Production and Cultivation27 stats
01
Over 500 million cannabis plants cultivated annually in Canada for legal market 2023
02
U.S. licensed cannabis cultivation facilities number 10,000+ in 2023, producing 2M lbs flower
03
California harvested 15 million pounds of cannabis in 2022, largest U.S. producer
04
Global hemp production reached 1.2 million metric tons in 2023, China leading at 70%
05
Michigan outdoor cannabis yields average 1.5 lbs per plant, highest in U.S. 2023
06
95% of U.S. CBD is hemp-derived, from 500,000 acres planted in 2023
07
Colombian cannabis flower exports hit 50 tons in 2023, up 300% YoY
08
Average THC content in U.S. flower rose to 20.5% in 2023 from 18% in 2020
09
Canada produced 2,200 metric tons of dried cannabis in 2023 legal market
10
Oregon cultivation licenses total 2,500, producing 10M lbs annually 2023
11
Indoor vs outdoor: 60% U.S. production indoor, costing $500/lb vs $100/lb outdoor 2023
12
Hemp seed production in U.S. reached 50,000 acres in 2023, yield 1,200 lbs/acre
13
Morocco illicit cannabis production estimated at 700 tons hashish annually, 2023 UNODC
14
U.S. greenhouse cannabis production up 40% to 25% market share in 2023
15
Average U.S. cannabis plant yield 0.5 lbs flower in craft grows, 2023 data
16
Lesotho produced 25 tons medical cannabis flower for export in 2023
17
Water usage in cannabis cultivation averages 6 gallons per plant daily in CA, 2023
18
80% of Canadian production is greenhouse/vertical farming in 2023
19
U.S. organic cannabis certified farms number 1,200, producing 15% supply 2023
20
Energy consumption for U.S. indoor grows equals 1% of state electricity in CA/NY
21
Thailand licensed 10,000 farms producing 500 tons CBD/hemp 2023
22
Pest management in cannabis: 70% use IPM, reducing pesticides 50% since 2020
23
U.K. indoor grows supply 90% domestic medical cannabis, 50 tons/year 2023
24
Automation in U.S. cultivation: 40% facilities use AI lighting/climate 2023
25
Global cannabinoid extraction capacity 100,000 liters CO2 annually 2023
26
Australia outdoor hemp yields 1 ton/acre CBD flower avg 2023
27
Waste from cannabis trim: 1M tons U.S. annually repurposed for extracts 2023
Interpretation
Production and Cultivation Interpretation
If you think the global green rush is just about a few plants in a basement, consider this: from Canada churning out enough cannabis to circle the Earth several times over, to China dominating hemp while Michigan perfects the art of the sun-grown plant, and with innovations in efficiency and energy use still racing to keep up with our soaring demand, it’s clear this industry has grown from a cottage curiosity into an agricultural and economic titan with a staggering global footprint—and we’re just getting started.
05 · Category
Regulatory and Legal Developments26 stats
01
24 U.S. states have adult-use cannabis legal as of 2024, up from 0 in 2012
02
Federal U.S. Schedule III rescheduling proposed for cannabis in May 2024 by DEA
03
Germany legalized recreational cannabis Feb 2024, allowing 25g possession
04
Canada collected CAD 1.5 billion in cannabis taxes since 2018 through 2023
05
U.S. banking reform SAFE Act passed House 2023 but stalled Senate, 321-101 vote
06
39 U.S. states have medical cannabis programs as of 2024
07
EU Novel Food regs cleared 20 CBD products for sale by 2023
08
Mexico legalized rec use 2021, regulated market sales began 2023 with 5 licenses
09
U.K. issued 45 medical cannabis licenses to 2023, prescriptions up 200%
10
U.S. 280E tax code repeal efforts: 70% revenue loss for operators 2023
11
Thailand decriminalized cannabis 2022, 8,000+ dispensaries licensed by 2023
12
Brazil approved medical cannabis self-cultivation 2023 for 1M patients
13
U.S. interstate commerce ban lifted in 3 states via compacts 2023 pilot
14
Malta first EU rec legal 2021, homegrow up to 4 plants, 500g possession 2023
15
FDA approved 3 cannabis-derived drugs: Epidiolex, Marinol, Syndros by 2023
16
U.S. hemp THC limit 0.3% dry weight per 2018 Farm Bill, tested 1M samples 2023
17
Luxembourg rec legal 2023, first EU with commercial sales planned 2024
18
2023 U.S. state tax revenue from cannabis: $3.7 billion collected
19
Czech Republic medical cannabis imports hit 5 tons 2023, homegrow legal up to 5 plants
20
U.S. expungements: 2 million cannabis convictions cleared post-legalization 2018-2023
21
Switzerland CBD limit raised to 1% THC in 2023 regs, boosting market
22
Global compliance software market for cannabis grew to $500M in 2023
23
Ohio rec legal voter-approved Nov 2023, sales start 2024 with 10% tax
24
Israel exported $200M medical cannabis to 20 countries under 2023 licenses
25
U.S. women in cannabis workforce 38% in 2023, up from 27% 2018
26
50+ countries have medical cannabis frameworks as of 2023
Interpretation
Regulatory and Legal Developments Interpretation
From zero states to two dozen, and from a Schedule I drug to a potential Schedule III, the once-fringe cannabis industry is now a global economic, legal, and social revolution being negotiated in courtrooms, pharmacies, and voting booths.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Felix Zimmermann. (2026, February 13). Cannabinoid Industry Statistics. Gitnux. https://gitnux.org/cannabinoid-industry-statistics
MLA
Felix Zimmermann. "Cannabinoid Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cannabinoid-industry-statistics.
Chicago
Felix Zimmermann. 2026. "Cannabinoid Industry Statistics." Gitnux. https://gitnux.org/cannabinoid-industry-statistics.
Sources & references
88 datasets cited across this report · attribution is report-level